The earlier review (31) (N=56 patients) uncovered higher levels of retrospectively assessed acute strain disorder indicators and present PTSD signs and symptoms amongst patients who acquired enantiomer esketamine, compared with individuals that obtained racemic ketamine or opioids; the racemic ketamine group also confirmed mildly elevated acute worry disorder signs compared https://henryz222uky9.oneworldwiki.com/user